Fresenius Medical Care sees Renal Care acquisition delayed till January/February

BAD HOMBURG, Germany (AFX) - Fresenius Medical Care AG's acquisition of US-based Renal Care may be delayed till January or February due to an extended evaluation of the takeover by US competition authorities, a spokesman said.

The competition authorities had originally planned to finalise the review before the end of the year.

Now, however, it has expressed concern that FMC may become too strong in certain regions, and could therefor demand that the dialysis services and products provider must sell some clinics.

This relates to 2-3 pct of Renal Care's patients.

Including the Renal Care Group, Fresenius Medical Care's annual sales will rise to above 8 bln eur next year for the first time.

fn/jsa [e-mail] rkj/jsa

COPYRIGHT

Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content,inculding by framing or similar means, is expressly prohibited without the prior written consent of AFX News.

AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited

For more information and to contact AFX: www.afxnews.com and www.afxpress.com